Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism 5-HT2C receptor agonists(Serotonin 2c (5-HT2c) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H15FN2 |
InChIKeyIGMTUJHDMPEPBD-CQSZACIVSA-N |
CAS Registry3081797-78-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Brain Diseases | Preclinical | United States | 21 May 2025 | |
| Brain Diseases | Preclinical | United States | 21 May 2025 |





